Optimizing mitochondrial-targeting groups of positively-charged BODIPY nanoparticles for enhanced photodynamic therapy
- 2 October 2024
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Materials Chemistry Frontiers
- Vol. 8 (23) , 3898-3905
Abstract
Mitochondria play an important role in regulating programmed cell death and various available mitochondrial-targeting photosensitizers are modified by cationic groups, especially triphenylphosphine (TPP). However, it's still a big challenge to develop novel mitochondrial-targeting photosensitizers, especially those that possess better performance than traditional TPP-modified photosensitizers. In this work, three cationic boron-dipyrromethene (BODIPY) nanoparticles with different mitochondrial-targeting groups (triphenylphosphine, trimethylamine and 1-methylimidazole) were designed and synthesized for enhanced photodynamic therapy. These BODIPY nanoparticles (BDPI NPs) could be endocytosed by various cancer cells and dissociated in the lysosomes. Subsequently, they escaped from the lysosomes due to the “proton-sponge” effect and were enriched on the inner membrane of mitochondria for enhanced photodynamic therapy. BDPI NPs could generate not only singlet oxygen (1O2) but also superoxide anions (O2 −˙), showing great type I and II photodynamic activity. Compared with TPP and the trimethylamine substitution, the 1-methylimidazole-modified nanoparticles (BDPI-IMA NPs) exhibited the most efficient mitochondrial-targeting capability and the most excellent photodynamic activity. This work highlights the great potential of 1-methylimidazole-modified photosensitizers and nanoparticles as highly efficient mitochondrial-specific probes and phototherapy agents.Keywords
Funding Information
- National Natural Science Foundation of China (52003267, 51973214)
This publication has 52 references indexed in Scilit:
- Hypoxia‐Responsive Photosensitizer Targeting Dual Organelles for Photodynamic Therapy of TumorsSmall, 2022
- An Enzyme‐Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis‐Based Synergistic Cancer TherapyAdvanced Materials, 2022
- Biodegradable Ca2+ Nanomodulators Activate Pyroptosis through Mitochondrial Ca2+ Overload for Cancer ImmunotherapyAngewandte Chemie International Edition, 2022
- Achieving Efficient NIR‐II Type‐I Photosensitizers for Photodynamic/Photothermal Therapy upon Regulating Chalcogen ElementsAdvanced Materials, 2021
- Ferroptosis Photoinduced by New Cyclometalated Iridium(III) Complexes and Its Synergism with Apoptosis in Tumor Cell InhibitionAngewandte Chemie International Edition, 2021
- A Cisplatin‐Selective Fluorescent Probe for Real‐Time Monitoring of Mitochondrial Platinum Accumulation in Living CellsAngewandte Chemie International Edition, 2020
- Mitochondria‐Specific Agents for Photodynamic Cancer Therapy: A Key Determinant to Boost the EfficacyAdvanced Healthcare Materials, 2020
- ROS‐Responsive Camptothecin Prodrug Nanoparticles for On‐Demand Drug Release and Combination of Chemotherapy and Photodynamic TherapyAdvanced Functional Materials, 2020
- Recent Progress in Near Infrared Light Triggered Photodynamic TherapySmall, 2017
- Red Blood Cell‐Facilitated Photodynamic Therapy for Cancer TreatmentAdvanced Functional Materials, 2016